Xiamen Tungsten

Phase A — Understand the business

Company Overview

Xiamen Tungsten is not one company; it is three commodity-processing businesses stapled together under a Fujian state holding company, and reading it as a "tungsten stock" is the first mistake most people make. FY2025 revenue split almost evenly between the two big legs, with rare earth a distant third:

The critical insight the revenue split hides: tungsten & molybdenum is ~42% of revenue but the dominant share of profit. The non-ferrous business booked FY2025 total profit of CNY 1.451bn on a 28.38% gross margin (+1.87pp YoY) — that single segment is ~63% of the group's CNY 2.309bn attributable net profit. The battery leg, despite carrying ~43% of revenue, throws off razor-thin margins (sub-sidiary XTC earned just CNY 494m net in 2024 on CNY 13.3bn revenue — a ~3.7% net margin — and Xiamen consolidates only ~half of it). Tungsten is the crown jewel; battery materials is the revenue diluent that depresses blended margin and ties the P&L to the lithium/cobalt price cycle.

Business model per leg:

• Tungsten: vertically integrated from mine/concentrate through APT, powder, cemented-carbide tooling and — the growth kicker — ultra-fine tungsten wire for photovoltaic silicon-wafer cutting, which has displaced high-carbon steel diamond wire. Xiamen is described as China's largest tungsten & molybdenum producer/exporter with world-leading smelting capacity, and it internally consumes ~68% of its carbide output, insulating it from spot swings. Contract structure is largely spot/index-linked (APT and concentrate reprice with the commodity), with cost pass-through across the chain.
• Battery: cathode sales indexed to lithium/cobalt/nickel input cost + a processing spread; 3C-consumer LCO is the franchise (recovering), NCM ternary is commoditizing.
• Rare earth: one of the state-authorised heavy-REE producers; has obtained rare-earth export licences and is exporting under the 2025 control regime.

Supply Chain

Map the tungsten chain end-to-end — names, not categories (this lens fails if it stays generic):

Upstream (feedstock — the pinch point):

• Own mines + concentrate: Xiamen operates/participates in scheelite and wolframite mining. Notable JV: Luoyang Yulu Mining (60% Xiamen / 40% CMOC Group [3993.HK/CMOC], which contributed molybdenum tailings for tungsten recovery) — produced 1,924 t WO₃ scheelite concentrate in 2025.
• China's tungsten mining quota (set by the Ministry of Natural Resources) was cut 6.5% in 2025 — the state throttles the top of the chain, which structurally advantages licensed insiders like Xiamen but starves independent smelters of feed.

Midstream (Xiamen's core — smelting/processing): concentrate → APT (ammonium paratungstate) → tungsten oxide → tungsten powder / tungsten carbide powder → cemented carbide (via subsidiary Xiamen Golden Egret / "Jinlu" Special Alloy) and ultra-fine tungsten wire. This is where Xiamen has global scale and the ~68% internal-consumption integration.

Downstream (customers / end markets):

• PV wafer cutters (tungsten diamond wire): the fastest-growing outlet — Longi, TCL Zhonghuan, JA Solar-tier wafer makers buy the wire (via diamond-wire fabricators). 62.8bn metres of PV tungsten wire sold in H1 2024 alone, >2x YoY.
• Cutting-tool / machining OEMs for cemented carbide (aerospace, autos, general machining).
• Defence / hardmetals — tungsten is a designated strategic metal; Western military demand is an explicit price driver in 2025-26.
• Export buyers (post-Feb-2025): only ~15 named Chinese firms may export tungsten under permit; China tungsten-powder exports to Japan (two major electronic-gas producers) reportedly hit zero, forcing permanent production halts there — a vivid illustration of Xiamen's leverage as a licensed exporter.

Battery chain (separate): lithium (Ganfeng/Tianqi-tier), cobalt (CMOC/Huayou), nickel → XTC precursors → cathode → cell makers (Sunwoda partnership on solid-state disclosed Dec 2024; CATL/ATL-tier 3C buyers).

Chokepoint verdict: the single-source dependency that matters is Xiamen's own concentrate feed. The CMOC/Luoyang Yulu suspension (below) proves the group is processing-long, feedstock-short in a super-cycle where feed is the scarce thing — a genuine vulnerability the revenue-scale story obscures.

Competitive Advantages (moats)

Xiamen's moat is policy + scale + integration, in that order — and the ranking matters because the first is not really Xiamen's own moat.

1. Regulatory position (the real, but rented, moat). Tungsten in China is quota-controlled at the mine, licence-controlled at the export gate, and Xiamen is on the inside of both regimes — one of ~15 firms cleared to export. This is a formidable barrier to everyone outside the licence list, but it is granted by Beijing, not built by Xiamen; the state can re-price it at will (see the rare-earth consolidation and the CMOC dispute). Call it a rented monopoly position, not a proprietary moat.
2. Scale + full-chain integration. World-leading tungsten smelting capacity, ~68% internal carbide consumption, and presence at every rung from oxide to finished wire. Cost/coverage advantage is real and durable.
3. Process/IP in ultra-fine tungsten wire. Diameters <25µm, break-resistance superior to diamond wire; tungsten wire cuts monocrystalline silicon with ~50% less wire consumption and thinner damage layers. This is a genuine engineering edge, but it is a share-gain product now ~80%+ penetrated — the moat is maturing.
4. LCO leadership (battery). XTC's ~44% global LCO share (2024) is a real #1, but LCO is a mature 3C-consumer chemistry with modest growth and commodity economics.

Bargaining power: strong over export buyers (licence scarcity), weak-to-neutral over feedstock (quota + JV partners like CMOC can and did squeeze), and weak in battery (price-takers on lithium/cobalt). Net: the moat is strongest exactly where policy is doing the work, which is the tell that this is a policy trade wearing a company's clothes.

Segments

FY2025 by segment (revenue):

Group trajectory:

• FY2024: revenue CNY 35.271bn (−10.48% YoY), attributable net profit CNY 1.740bn (+8.60%) — the paradox year: revenue fell (lithium/cobalt deflation shrank battery revenue) while profit rose (tungsten mix richened). This is the single most important structural fact in the numbers: the group makes more money when its biggest revenue line shrinks, because battery revenue is low-quality.
• FY2025: revenue CNY 46.265bn (+30.79%), attributable net profit CNY 2.309bn (+34.89%) — tungsten price lift + battery-volume recovery.
• Q1 2026: revenue CNY 15.74bn (+86.99%), attributable net profit CNY 1.11bn (+189.14%) — the tungsten super-cycle in full force; cost pass-through inflating both revenue and margin.

(Conflict flagged & resolved: one aggregator returned "2024 revenue CNY 53.59bn" — contradicted by three independent sources and the company's own "−10.48%/+8.60%" release. The CNY 35.271bn / 1.740bn figures are used; the 53.59bn figure is discarded as garbled.)

---

Phase B — Measure performance

Earnings Result (latest print — Q1 2026)

The latest print is explosive and cyclical: Q1 2026 revenue CNY 15.74bn, +86.99% YoY; attributable net profit CNY 1.11bn, +189.14% YoY. Drivers:

• Tungsten price pass-through. 65% black-tungsten concentrate hit CNY 1.028m/t in 2026, +125% from CNY 457k/t at the start of the year; APT set records. Xiamen re-prices the whole chain up, and with ~68% internal integration it captures the spread rather than passing it all through.
• Margin expansion, not just price. Tungsten-moly gross margin reached 28.38% in FY2025 (+1.87pp) and is widening further in 2026 as price outruns cost.
• Battery recovery adds volume (LCO 3C rebound) but little margin.

Balance-sheet / quality flags to watch: with commodity prices spiking, working capital is the thing to interrogate — inventory and receivables can balloon faster than cash during a price melt-up, and cost pass-through can reverse violently. Specific WC lines are n/a (no filing on the shelf; Chinese interim disclosure is thin in English). Market reaction: the stock made an all-time high of CNY 81.56 on 4 Mar 2026 (a short-term double) and has since pulled back ~20% to CNY 65.11 — the market is treating peak-cycle prints with appropriate suspicion.

Earnings Calls (sentiment trend)

Limitation, stated plainly: Xiamen is an A-share SOE and does not hold English-language earnings calls; there are no transcripts on the shelf or the public web to run sentiment on. Proxy read from management commentary in results releases and Chinese filings:

• 2023 → mid-2024 (defensive): commentary centred on weathering the lithium/cobalt price collapse, battery-materials revenue pressure, and "self-sufficiency" in raw materials — a company managing down a cyclical trough in its biggest revenue line.
• 2025 (inflecting): language shifts to tungsten-price strength, PV tungsten-wire volume records, and export-licence positioning.
• 2026 (confident/expansionary): cost pass-through, "prosperity continues" framing on tungsten & molybdenum, capacity and integration emphasis.

The tonal arc is real but commodity-driven, not strategy-driven — management's confidence tracks the APT price, which is the honest way to read it. The thing they stopped saying is the 2023-vintage anxiety about battery-materials margins; the thing they started saying is raw-material security — which the CMOC dispute then immediately tested.

Comps

Xiamen sits awkwardly between two comp sets — Chinese SOE tungsten/materials names, and the Western "supply-security premium" rare-earth stocks.

Read: on sales, Xiamen at ~2.2x is an order of magnitude cheaper than MP/Lynas at ~20x — but that gap is correct, not an opportunity: MP/Lynas are near-breakeven story stocks priced on Western supply-security scarcity, while Xiamen is a profitable, taxed, state-directed Chinese cyclical. On its own history, Xiamen at ~20x forward earnings and 17x EV/EBITDA on peak-cycle tungsten is not cheap — that is a full multiple on top-of-cycle earnings, which is how cyclicals set bull traps. The most useful comp for an actionable trade is Almonty (AII.TO): same tungsten tailwind, no China governance/ownership friction, and (per North-Star coverage rules favouring being early in ex-China frontier supply) a cleaner vehicle for MenFem's audience.

Stock-Price Catalysts (5-year pattern)

What actually moves 600549:

• 2021: PV tungsten-wire growth story begins (diamond-wire displacement) — first re-rating leg.
• 2022: lithium peak — battery-materials revenue peaks; group revenue near cyclical high on input-cost inflation (low-quality revenue).
• 2023–2024: lithium/cobalt crash — battery revenue deflates; stock de-rates; the "revenue down, profit up" paradox emerges.
• 4 Feb 2025: China adds tungsten to the export-control list (permits; ~15 licensed exporters) — the structural catalyst. Tungsten products +200%+ through 2025; export volumes −40% YoY.
• 2025 → Mar 2026: super-cycle — 65% concentrate +125% YTD 2026; stock +222% over 52 weeks, ATH CNY 81.56 on 4 Mar 2026, then a ~20% pullback to ~CNY 65.
• Jun–Jul 2026: CMOC halts Luoyang Yulu tailings supply → JV suspended; shares reportedly up ~3% on the news (market read it as further supply tightening).

Pattern: the market reacts to the tungsten price and Chinese state policy far more than to any company-specific execution. This is a commodity-and-policy beta, not an operational compounder. The single most important variable for the next 12 months is the APT/concentrate price, followed by export-quota policy — neither of which management controls.

---

Phase C — Judge people & books

Management & Ownership

Ownership — this is a state-controlled enterprise, full stop. Controlling shareholder is Fujian Metallurgical (Holding) Co., Ltd at ~31% (30.69% Dec-2024, ~31% by Feb-2025), which has been increasing its stake (bought +1.66m shares) — a modestly positive alignment signal. China Minmetals holds ~7.68%. Ultimate control traces to SASAC (Fujian provincial + central via Minmetals). Governance implication: exports and asset structure serve Beijing's industrial strategy first, minority shareholders second — the rare-earth consolidation (Lens 13) is the proof.

Leadership: long-tenured SOE management (chairman/president in seat since ~2015; chairman comp ~CNY 1.5m ≈ $210k in 2024 — typical low SOE pay, meaning near-zero equity-style skin in the game for operators; alignment runs through the state parent, not management shareholding). (Exact current names return conflicting web values — treated as n/a — not reliably sourced rather than asserted.)

Capital allocation: disciplined-to-conservative. Retained the high-margin tungsten core while listing (not selling) the battery arm — XTC's 2021 STAR-Market IPO crystallised value while keeping 50% control and consolidation. Dividend is token (~0.9% yield, CNY 0.58) — capital is retained for integration/capex, appropriate for a cyclical but unfriendly to income holders. ROE 16.85% is respectable for a materials SOE. Red flags: related-party complexity (Fujian-state web, multiple listed subs 600549/688778), and the structural subordination of minority interests to state consolidation goals.

Forensic Red Flags

Analytical caution items (no filing on the shelf — all /inference; specific line items n/a):

1. Commodity working-capital risk (highest-priority watch). In a +100–200% price melt-up, inventory and receivables can inflate faster than operating cash. With Q1'26 revenue +87%, the diligence question is whether operating cash flow tracked net income or lagged it — not verifiable from public English sources; flag for the interim report.
2. Consolidation optics. ~43% of revenue is the 50%-owned XTC battery sub — consolidated at 100% of revenue with ~50% minority interest below the line. Group revenue therefore overstates Xiamen's economic scale, and blended margin is dragged by a business it half-owns. Read attributable net profit, not revenue.
3. Cost pass-through reversal. The margin expansion is price-driven; when tungsten normalises, the same pass-through mechanism compresses margins on the way down. Peak-margin ≠ structural margin.
4. Segment-reporting opacity. Chinese-GAAP segment detail is thinner than US 10-KForm 10-KA company’s audited annual report to the US regulator. The most complete thing it publishes. standard; the 28.38% tungsten GM and CNY 1.451bn segment profit are the disclosed anchors, but sub-segment (wire vs carbide vs APT) economics are not cleanly broken out.

Regulatory findings (required sub-section).

• SEC (EDGAR): regulatory/regulatory-findings.md records 0 findings — Xiamen has no CIK and no SEC jurisdiction (not a US filer). No LR/AAER possible.
• Non-SEC / China: web search surfaces no material fraud/enforcement action against the parent. The live item is the CMOC / Luoyang Yulu compliance dispute (Jun–Jul 2026): CMOC halted tailings supply citing tungsten-mining compliance under the tightening quota regime; Xiamen said CMOC raised new cooperation demands. This is a commercial/regulatory dispute, not an accounting-fraud flag, but it exposes raw-material insecurity and JV-governance risk.
• Item 3 (Legal Proceedings) equivalent: n/a — no 10-K on the shelf; Chinese annual-report litigation disclosure not retrieved in English.
• Net: No material regulatory or accounting-fraud findings identified via SEC EDGAR (no jurisdiction), web search, and available disclosure as of 2026-07-10. One live commercial/compliance dispute (CMOC) flagged.

---

Phase D — Project & stress-test

Forward Projection (base / bull / bear)

Built bottom-up off FY2025 actuals + the Q1'26 run-rate. Shares outstanding ~1.59bn; FY2025 attributable NP CNY 2.309bn → FY2025 EPS ≈ CNY 1.45. (Per the watchlist rule and this run's constraints, no our model forecast is logged.)

FY2027–28 hinge almost entirely on whether tungsten holds — base case assumes normalisation off the 2026 peak, so EPS likely plateaus then modestly declines from a 2026 peak rather than compounding (the cyclical's tell): FY2027E EPS ~CNY 2.1–2.4, FY2028E ~CNY 1.9–2.3. At CNY 65.11, the stock is ~27x FY2025 EPS and ~20x base FY2026E EPS — i.e. paying a full multiple for peak-cycle earnings. That is the crux of the caution.

Bull vs Bear

Bull case. Xiamen is the single best-positioned Chinese vehicle for a genuine, policy-manufactured tungsten super-cycle: on the inside of both the mining quota and the export licence, world-scale integration, ~68% internal carbide consumption capturing the spread, and a real PV-tungsten-wire share-gain product. Q1'26 net +189% is not noise — it's cost pass-through on a strategic metal the West cannot easily source (China tungsten exports to Japan hit zero). Add optionality: a 49% economic stake in a consolidated national heavy-REE champion (dysprosium/terbium — the most export-strategic REEs) and a #1 global LCO franchise recovering off trough. If tungsten stays scarce (military + AI-toolchain + PV demand vs −6.5% quota, −40% exports), FY2026 earnings re-rate the whole group.

Bear case (2–3 permanent-impairment risks).

1. It's a cyclical at the top wearing a growth multiple. +222% in 52 weeks; ~20x forward on peak tungsten. When APT normalises, the pass-through that expanded margins compresses them, and the multiple and the E fall together.
2. Feedstock insecurity is rising, not falling. The CMOC/Luoyang Yulu suspension shows even JV partners will pull feed as quota compliance tightens — Xiamen is processing-long/feed-short exactly when feed is the scarce asset.
3. State subordination of minority holders. The rare-earth business is being consolidated into CREG-controlled JVs (CREG 51% / Xiamen 49%) — Xiamen is ceding operational control of a strategic segment to a central SOE. The state reorganises assets around policy, not around 600549's minority shareholders.

Pre-mortem (18 months out, thesis broke): tungsten corrected 30% off the 2026 peak as high prices triggered demand destruction (wafer cutters thrift tungsten wire; export buyers designed around Chinese supply) and quota relaxed; battery margins stayed thin; the group printed a lower 2027 EPS off a 2026 peak, and the 20x multiple compressed to 12x — a ~40% drawdown despite a "structurally intact" story. Contrarian view the market is refusing to see: the market is trading 600549 as a secular winner when it is a policy-beta cyclical whose best segment it doesn't fully control and whose feed it can't guarantee.

Devil's Advocate (short-seller)

Dismantling the bull case: The bull thesis is entirely a bet on the tungsten price and on Beijing keeping the export screws tight — neither is a company moat. Structural break points:

• Revenue concentration is a mirage of quality. The biggest revenue line (battery, 43%) is a low-margin price-taker; the profit line (tungsten) is a policy grant, not a franchise. Strip the policy and you have a mid-teens-ROE Chinese processor at 20x.
• The most dangerous competitor bulls underrate is the Chinese state itself — via China Tungsten & Hightech (000657, Minmetals) on carbide and via CREG on rare earth. The consolidation logic that just took Xiamen's REE independence can be pointed at tungsten next; Minmetals already owns 7.68% of Xiamen and controls a rival tungsten champion.
• Worst capital-allocation / governance exposure: minority holders sit below the state's strategic objectives. The CREG JV (49%) and the CMOC feed dispute both show Xiamen absorbing terms set by more powerful state actors.
• What must hold for CNY 65: tungsten stays near record levels through 2026-27 and the market keeps paying ~20x for it. If growth disappoints 20–30% (tungsten normalises), base EPS drops toward the bear ~CNY 1.9 and a de-rate to 12–14x implies a CNY ~27–33 stock — roughly 50% downside.
• Single permanent-impairment scenario (plausibility: moderate): a coordinated state consolidation folds Xiamen's tungsten assets into a Minmetals-led national champion on non-market terms — strategically logical for Beijing, value-destructive for 600549 minorities. Not imminent, but the rare-earth precedent makes it non-trivial.

Management Questions (ordered by information value)

1. What share of your tungsten concentrate feed is self-supplied vs. purchased, and how exposed is the group to further JV/feedstock disruptions like Luoyang Yulu?
2. At what tungsten price does the current margin structure normalise — i.e., how much of the 28.38% tungsten GM is structural vs. pass-through timing?
3. What is the end-game for the rare-earth business under the CREG framework — will Xiamen retain any operational control, or is it a pure 49% financial stake?
4. Could the tungsten segment be subject to the same central-SOE consolidation that reorganised rare earth? What assurances exist for 600549 minority holders?
5. How sustainable is PV tungsten-wire volume growth now that penetration exceeds ~80% — is future growth purely a function of solar installation volume?
6. What is operating cash flow conversion in the price melt-up — are receivables/inventory growing faster than revenue?
7. What is the strategic rationale for keeping the 50% XTC stake rather than deconsolidating a low-margin business that dilutes group margin?
8. How exposed are export volumes to Western "designing-out" of Chinese tungsten, and what is the demand-destruction price threshold?
9. What is the capexCapital expenditureMoney spent on long-lived things — buildings, machines, servers — rather than on running costs. plan and funding for tungsten-chain integration over 2026–28, and expected returns?
10. How does management think about returning capital (buyback/dividend) given the token ~0.9% yield and a cyclical earnings peak?
11. What is the molybdenum contribution and outlook within the non-ferrous segment?
12. How does the Sunwoda solid-state partnership change XTC's cathode roadmap and margin profile?
13. What is the group's exposure to lithium/cobalt price re-inflation on the battery side?
14. How does the export-licence regime affect pricing power vs. domestic Chinese buyers?
15. What ESG/permitting/tailings-reclassification risks (per the CMOC compliance framing) could constrain mining or processing volume?

---